Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants
CA 2205442 C · Owner: Amarin Development Ab · Inventors: Parasrampuria, Jagdish; Kuhrts, Eric H.; Yu, Karen
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An oral-delivery pharmaceutical composition for reducing the gastric irritation effect of an NSAID in the upper GI tract of a mammal. The composition includes (a) a mucosal protective amount of a pharmaceuticallyacceptable hydrocolloid gum obtainable from higher plants (b) a dispersion-, enhancing amount of another excipient and (c) a therapeutically-effective amount of an NSAID. Also disclosed is a process for preparing the composition and a method for reducing the gastric irritation effect of the NSAID by administering the composition. Also, disclosed is a composition particularly useful for preparing an aqueous suspension.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 30, 1995 and granted January 21, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 30, 2015.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 30, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.